EcoDrugPlus

Cytochrome P450 340p1

Ensembl ID : HMEL013954
Gene Symbol: CYP340P1
1 External references
153 Possible Orthologues:

Cytochrome P450 340q1

Ensembl ID : HMEL010935
Gene Symbol: CYP340Q1
1 External references
154 Possible Orthologues:

Cytochrome P450 340r2

Ensembl ID : HMEL010931
Gene Symbol: CYP340R2
1 External references
154 Possible Orthologues:

Cytochrome P450 340r4

Ensembl ID : HMEL013956
Gene Symbol: CYP340R4
1 External references
154 Possible Orthologues:

Cytochrome P450 340r6

Ensembl ID : HMEL013957
Gene Symbol: CYP340R6
1 External references
154 Possible Orthologues:

Cytochrome P450 341a10

Ensembl ID : HMEL017150
Gene Symbol: CYP341A10
1 External references
151 Possible Orthologues:

Cytochrome P450 341a8

Ensembl ID : HMEL017148
Gene Symbol: CYP341A8
1 External references
151 Possible Orthologues:

Cytochrome P450 341a9

Ensembl ID : HMEL017149
Gene Symbol: CYP341A9
1 External references
151 Possible Orthologues:

Cytochrome P450 341f1

Ensembl ID : HMEL006318
Gene Symbol: CYP341F1
1 External references
151 Possible Orthologues:

Cytochrome P450 367b3

Ensembl ID : HMEL002115
Gene Symbol: CYP367B3
1 External references
151 Possible Orthologues:

Cytochrome P450 405a4

Ensembl ID : HMEL016675
Gene Symbol: CYP405A4
1 External references
150 Possible Orthologues:

Cytochrome P450 405a5

Ensembl ID : HMEL016673
Gene Symbol: CYP405A5
1 External references
150 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).